The Explorer TO Expandable Interbody System provides an innovative and elegant posterior interbody solution that offers two types of implants — one expanding in height, the other in lordosis — that are compatible with the same instrumentation
SeaSpine announces the launch of Explorer TO Expandable Interbody System
SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Explorer TO (TLIF Oblique) Expandable Interbody System.
The Explorer TO Expandable Interbody System provides an innovative and elegant posterior interbody solution that offers two types of implants — one expanding in height, the other in lordosis — that are compatible with the same instrumentation. Notably, Explorer TO is designed to streamline allograft or autograft delivery post-implantation and expansion.
Explorer TO represents SeaSpine’s first expandable interbody system from the Explorer family. Building off the Company’s foundational Explorer technology, SeaSpine expects to launch additional expandable interbody systems that will accommodate different approaches and techniques in the future and that, collectively, address a market segment that SeaSpine estimates to exceed $450 million in the United States alone.
“As a minimally invasive spine surgeon, I am always looking for an interbody device that minimizes tissue and nerve disruption, while maximizing height restoration,” stated Dr. Azam Basheer of Henry Ford Hospital. “Despite the cage’s slim profile and tapered nose, it offers an immense amount of continuous distraction force to maximize foraminal height and sagittal balance restoration.”
“We designed Explorer TO with both minimally invasive and complex open deformity surgeons in mind, addressing both TLIF and PLIF needs required in profile, robustness, and post-packability,” said Shaeffer Bannigan, Vice President, Product Development. “This new product offering allows SeaSpine to compete in the expandable interbody market in a much more effective and complete manner than we could in the past.”
Source: Company Press Release